Embryonic stem (ES) cell-derived cardiomyocytes: A good candidate for cell therapy applications

Cell Biology International

Volumn 33, Issue 3, 2009, Pages 325-336

  Pal, Rajarshi ^a  

^a Manipal Academy of Higher Education   (India)

Author keywords

Cardiac regeneration; Cardiomyocytes; Cell replacement therapy; Characterization; Differentiation; Embryonic stem cells; Engraftment; Precardiac mesoderm; Transplantation

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIABETES MELLITUS; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; HEART DEVELOPMENT; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MAMMAL; MESODERM; NONHUMAN; PARKINSON DISEASE; SOMATIC CELL; SOMATIC CELL THERAPY; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TRANSCRIPTION REGULATION;

BONE MARROW CELLS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; MYOCYTES, CARDIAC;

RODENTIA;

EID: 61349113322     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2008.12.001     Document Type: Article

References (116)

1. Agbulut O., Menot M.L., Li Z., Marotte F., Paulin D., Hagege A.A., et al. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovasc Res 58 (2003) 451-459
2. Alsan B.H., and Schultheiss T.M. Regulation of avian cardiogenesis by Fgf8 signaling. Development 129 8 (2002) 1935-1943
3. Anderson D., Self T., Mellor I.R., Goh G., Hill S.J., and Denning C. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther (2007) 10.1038/sj.mt.6300303
4. Andrée B., Duprez D., Vorbusch B., Arnold H.H., and Brand T. BMP-2 induces ectopic expression of cardiac lineage markers and interferes with somite formation in chicken embryos. Mech Dev 70 1-2 (1998) 119-131
5. Barron M., Gao M., and Lough J. Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Dev Dyn 218 2 (2000) 383-393
6. Bettiol E., Sartiani L., Chicha L., Krause K.H., Cerbai E., and Jaconi M.E. Fetal bovine serum enables cardiac differentiation of human embryonic stem cells. Differentiation (2007) 10.1111/j.1432-0436.2007.00174
7. Binah O., Dolnikov K., Sadan O., Shilkrut M., Zeevi-Levin N., Amit M., et al. Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes. J Electrocardiol 40 (2007) S192-S196
8. Bodmer R. The gene tinman is required for specification of the heart and visceral muscles in Drosophila. Development 118 3 (1993) 719-729
9. Boheler K.R., Czyz J., Tweedie D., Yang H.T., Anisimov S.V., and Wobus A.M. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 91 3 (2002) 189-201
10. Brand T. Heart development: molecular insights into cardiac specification and early morphogenesis. Dev Biol 258 (2003) 1-19
11. Cai J., Yi F.F., Yang X.C., Lin G.S., Jiang H., Wang T., et al. Transplantation of embryonic stem cell-derived cardiomyocytes improves cardiac function in infarcted rat hearts. Cytotherapy 9 3 (2007) 283-291
12. Caplice N.M., and Gersh B.J. Stem cells to repair the heart: a clinical perspective. Circ Res 92 (2003) 6-8
13. Civin C.I., and Rao M.S. How many human embryonic stem cell lines are sufficient? A US perspective. Stem Cells 24 4 (2006) 800-803
14. Collins S.D., Baffour R., and Waksman R. Cell therapy in myocardial infarction. Cardiovasc Revasc Med 8 (2007) 43-51
15. Cui L., Johkura K., Takei S., Ogiwara N., and Sasaki K. Structural differentiation, proliferation, and association of human embryonic stem cell-derived cardiomyocytes in vitro and in their extracardiac tissues. J Struct Biol 158 (2007) 307-317
16. Dai W., Hale S.L., Martin B.J., Kuang J.Q., Dow J.S., Wold L.E., et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112 2 (2005) 214-223
17. Dai W., Field L.J., Rubart M., Reuter S., Hale S.L., Zweigerdt R., et al. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol (2007) 10.1016/j.yjmcc.2007.07.001
18. Denning C., Allegruci C., Priddle H., Barbadillo-Munoz M.D., Anderson D., Self T., et al. Common culture conditions for maintenance and cardiomyocyte differentiation of the human embryonic stem cell lines, BG01 and HUES-7. Int J Dev Biol 50 (2006) 27-37
19. DeRuiter M.C., Poelmann R.E., VanderPlas-de Vries I., Mentink M.M., and Gittenberger-de Groot A.C. The development of the myocardium and endocardium in mouse embryos. Fusion of two heart tubes?. Anat Embryol (Berl) 185 5 (1992) 461-473
20. Doss M.X., Koehler C.I., Gissel C., Hescheler J., and Sachinidis A. Embryonic stem cells: a promising tool for cell replacement therapy. J Cell Mol Med 8 4 (2004) 465-473
21. Dowell J.D., Rubart M., Pasumarthi K.B., Soonpaa M.H., and Field L.J. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 58 2 (2003) 336-350
22. Drukker M., Katz G., Urbach A., Schuldiner M., Markel G., Itskovitz-Eldor J., et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci 99 (2002) 9864-9869
23. Drukker M., and Benvenisty N. The immunogenicity of human embryonic stem derived cells. Trends Biotechnol 22 (2004) 136-141
24. Drukker M., Katchman H., Katz G., Even-Tov Friedman S., Shezen E., Hornstein E., et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24 2 (2006) 221-229
25. Etzion S., Battler A., Barbash I.M., Cagnano E., Zarin P., Granot Y., et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol 33 (2001) 1321-1330
26. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
27. Fändrich F., Dresske B., Bader M., and Schulze M. Embryonic stem cells share immune-privileged features relevant for tolerance induction. J Mol Med 80 6 (2002) 343-350
28. Filipczyk A.A., Passier R., Rochat A., and Mummery C.L. Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signaling. Cell Mol Life Sci (2007) 10.1007/s00018-007-6523-2
29. Fodor W.L. Tissue engineering and cell based therapies, from the bench to the clinic: the potential to replace, repair and regenerate. Reprod Biol Endocrinol 1 (2003) 102
30. Goldman-Johnson D.R., de Kretser D.M., and Morrison J.R. Evidence that androgens regulate early developmental events, priorto sexual differentiation. Endocrinology 149 1 (2008) 5-14
31. Goh G., Self T., Barbadillo Muñoz M.D., Hall I.P., Young L., and Denning C. Molecular and phenotypic analyses of human embryonic stem cell-derived cardiomyocytes: opportunities and challenges for clinical translation. Thromb Haemost 94 4 (2005) 728-737
32. Graichen R., Xu X., Braam S.R., Balakrishnan T., Norfiza S., Sieh S., et al. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation (2007) 10.1111/j.1432-0436.2007.00236
33. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., and Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270 5239 (1995) 1189-1192
34. Gupta R., Joshi P., Mohan V., Reddy K.S., and Yusuf S. Epidemiology and causation of coronary heart disease and stroke in India. Heart 94 1 (2008) 16-26
35. He J.Q., Ma Y., Lee Y., Thomson J.A., and Kamp T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 93 (2003) 32-39
36. Heikinheimo M., Scandrett J.M., and Wilson D.B. Localization of transcription factor GATA-4 to regions of the mouse embryo involved in cardiac development. Dev Biol 164 2 (1994) 361-373
37. Himes N., Min J.Y., Lee R., Brown C., Shea J., Huang X., et al. In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction. Magn Reson Med 52 (2004) 1214-1219
38. Hodgson D.M., Behfar A., Zingman L.V., Kane G.C., Perez-Terzic C., Alekseev A.E., et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 287 (2004) H471-H479
39. Ishida M., Tomita S., Nakatani T., Fukuhara S., Hamamoto M., Noritoshi N., et al. Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathy. J Heart Lung Transplant 23 4 (2003) 436-445
40. Itskovitz-Eldor J., Schuldiner M., Karsenti D., Eden A., Yanuka O., Amit M., et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6 2 (2000) 88-95
41. Kalyanaraman B., Joseph J., Kalivendi S., Wang S., Konorev E., and Kotamraju S. Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem 234-235 (2002) 119-124
42. Kattman S.J., Adler E.D., and Keller G.M. Specification of multipotential cardiovascular progenitor cells during embryonic stem cell differentiation and embryonic development. Trends Cardiovasc Med 17 7 (2007) 240-246
43. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108 (2001) 407-414
44. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22 (2004) 1282-1289
45. Kispert A., and Hermann B.G. The Brachyury gene encodes a novel DNA binding protein. EMBO J 12 12 (1993) 4898-4899
46. Kispert A., and Herrmann B.G. Immunohistochemical analysis of the Brachyury protein in wild-type and mutant mouse embryos. Dev Biol 161 1 (1994) 179-193
47. Klaus A., Saga Y., Taketo M.M., Tzahor E., and Birchmeier W. Distinct roles of Wnt/beta-catenin and Bmp signaling during early cardiogenesis. Proc Natl Acad Sci USA 104 47 (2007) 18531-18536
48. Klug M.G., Soonpaa M.H., Koh G.Y., and Field L.J. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 98 (1996) 216-221
49. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 4 (2001) 430-436
50. Kofidis T., de Bruin J.L., Yamane T., Balsam L.B., Lebl D.R., Swijnenburg R.J., et al. Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 22 (2004) 1239-1245
51. Kofidis T., de Bruin J.L., Yamane T., Tanaka M., Lebl D.R., Swijnenburg R.J., et al. Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury. Circulation 111 19 (2005) 2486-2493
52. Kofidis T., Lebl D.R., Swijnenburg R.J., Greeve J.M., Klima U., and Robbins R.C. Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. Eur J Cardiothorac Surg 29 (2006) 50-55
53. Kolossov E., Fleischmann B.K., Liu Q., Bloch W., Viatchenko-Karpinski S., Manzke O., et al. Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein. J Cell Biol 143 7 (1998) 2045-2056
54. Komuro I., and Izumo S. Csx: a murine homeobox-containing gene specifically expressed in the developing heart. Proc Natl Acad Sci USA 90 17 (1993) 8145-8149
55. Laflamme M.A., and Murry C.E. Regenerating the heart. Nat Biotechnol 23 (2005) 845-856
56. Laflamme M.A., Gold J., Xu C., Hassanipour M., Rosler E., Police S., et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 167 (2005) 663-671
57. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.A., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infracted rat hearts. Nat Biotechnol 25 9 (2007) 1015-1024
58. Laugwitz K.L., Moretti A., Caron L., Nakano A., and Chien K.R. Islet1 cardiovascular progenitors: a single source for heart lineages?. Development 135 2 (2008) 193-205
59. Lawson K.A., Meneses J.J., and Pedersen R.A. Clonal analysis of epiblast fate during germ layer formation in the mouse embryo. Development 113 3 (1991) 891-911
60. Leor J., Nir S.G., Cohen S., Miller L., Holbova R., Ziskind A., et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart (2007) 10.1136/hrt.2006.093161 (published online 12 June)
61. Li L., Baroja M.L., Majumdar A., Chadwick K., Rouleau A., Gallacher L., et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 22 4 (2004) 448-456
62. Lints T.J., Parsons L.M., Hartley L., Lyons I., and Harvey R.P. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 119 3 (1993) 969
63. Lough J., and Sugi Y. Endoderm and heart development. Dev Dyn 217 (2000) 327-342
64. Lyons I., Parsons L.M., Hartley L., Li R., Andrews J.E., Robb L., et al. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9 13 (1995) 1654-1666
65. Malek S., Kaplan E., Wang J.F., Ke Q., Rana J.S., Chen Y., et al. Successful implantation of intravenously administered stem cells correlates with severity of inflammation in murine myocarditis. Pflugers Arch Jan 26 (2006) 1-8
66. 2+ current in the early stages of cardiomyocyte development. Circ Res 84 2 (1999) 136-145
67. Ménard C., Hagège A., Agbulut O., Barro M., Morichetti C., Brasselet C., et al. Xenograft of cardiac committed embryonic stem cells to infarcted sheep myocardium improves left ventricular function: a preclinical study. Lancet 366 9490 (2005) 1005-1012
68. Merscher S., Funke B., Epstein J.A., Heyer J., Puech A., Lu M.M., et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104 4 (2001) 619-629
69. Meyer N., Jaconi M., Landopoulou A., Fort P., and Pucéat M. A fluorescent reporter gene as a marker for ventricular specification in ES-derived cardiac cells. FEBS Lett 478 (2000) 151-158
70. Min J.Y., Yang Y., Converso K.L., Liu L., Huang Q., Morgan J.P., et al. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 92 (2002) 288-296
71. Min J.Y., Huang X., Xiang M., Meissner A., Chen Y., Ke Q., et al. Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction. J Thorac Cardiovasc Surg 131 4 (2006) 889-897
72. Mitalipova M.M., Calhoun J.D., Shin S., Wininger W., Schulz T.C., Noggle S.A., et al. Human embryonic stem cell lines derived from discarded embryos. Stem Cells 21 (2003) 521-526
73. + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127 6 (2006) 1151-1165
74. Morrisey E.E., Ip H.S., Lu M.M., and Parmacek M.S. GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm. Dev Biol 177 1 (1996) 309-322
75. Morrisey E.E., Ip H.S., Tang Z., and Parmacek M.S. GATA-4 activates transcription via two novel domains that are conserved within the GATA-4/5/6 subfamily. J Biol Chem 272 13 (1997) 8515-8524
76. Müller M., Fleischmann B.K., Selbert S., Ji G.J., Endl E., Middeler G., et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 14 15 (2000) 2540-2548
77. Mummery C., Ward D., van den Brink C.E., Doevendans P.A., Opthof T., Brutel de la Riviere A., et al. Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat 200 (2002) 233-242
78. Mummery C., Ward-van Oostwaard D., Doevendans P., Spijker R., van den Brink S., Hassink R., et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107 (2003) 2733-2740
79. Naito H., Nishizaki K., Yoshikawa M., Yamada T., Satoh H., Nagasaka S., et al. Xenogeneic embryonic stem cell derived cardiomyocyte transplantation. Transplant Proc 36 (2004) 2507-2508
80. Nascone N., and Mercola M. An inductive role for the endoderm in Xenopus cardiogenesis. Development 121 2 (1995) 515-523
81. Norstrom A., Karolina A.K., Hardarson T., Hamberger L., Bjorquist P., and Sartipy P. Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes. Exp Biol Med (Maywood) 231 11 (2006) 1753-1762
82. Pal R., and Khanna A. Role of hepatocyte-like cells in differentiation of cardiomyocytes from mouse ES cells. Stem Cells Dev 14 (2005) 153-161
83. Pal R., and Khanna A. A Smad and Wnt-dependent pathway in embryonic cardiac development. Stem Cells Dev 15 (2006) 29-39
84. Pal R., and Khanna A. Heart development: the battle between mesoderm and endoderm. Stem Cells Dev 16 1 (2007) 3-5
85. Parameswaran M., and Tam P.P. Regionalisation of cell fate and morphogenetic movement of the mesoderm during mouse gastrulation. Dev Genet 17 1 (1995) 16-28
86. Passier R., Oostwaard D.W., Snapper J., Kloots J., Hassink R.J., Kuijk E., et al. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 23 (2005) 772-780
87. Plageman Jr. T.F., and Yutzey K.E. T-box genes and heart development: putting the "T" in heart. Dev Dyn 232 1 (2005) 11-20
88. Rathjen J., Lake J.A., Bettess M.D., Washington J.M., Chapman G., and Rathjen P.D. Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors. J Cell Sci 112 Pt 5 (1999) 601-612
89. Rathjen J., and Rathjen P.D. Mouse ES cells: experimental exploitation of pluripotent differentiation potential. Curr Opin Genet Dev 11 5 (2001) 587-594
90. Reinecke H., Zhang M., Bartosek T., and Murry C.E. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100 (1999) 193-202
91. Schultheiss T.M., Burch J.B., and Lassar A.B. A role of bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev 11 (1997) 446-451
92. Schwarz E.R., Pollick C., Meehan W.P., and Kloner R.A. Evaluation of cardiac structures and function in small experimental animals: transthoracic, transesophageal, and intraventricular echocardiography to assess contractile function in rat heart. Basic Res Cardiol 93 6 (1998) 477-486
93. Singla D.K., Hacker T.A., Ma L., Douglas P.S., Sullivan R., Lyons G.E., et al. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J Mol Cell Cardiol 40 (2006) 195-200
94. Singla D.K., Lyons G.E., and Kamp T.J. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol 293 2 (2007) H1308-H1314
95. Snir M., Kehat I., Gepstein A., Coleman R., Itskovitz-Eldor J., Livne E., et al. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 285 6 (2003) H2355-H2363
96. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell 126 6 (2006) 1037-1048
97. Swijnenburg R.J., Tanaka M., Vogel H., Baker J., Kofidis T., Gunawan F., et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112 (2005) I166-I172
98. Tada M., Takahama Y., Abe K., Nakatsuji N., and Tada T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11 19 (2001) 1553-1558
99. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
100. Tian L., Catt J.W., O'Neill C., and King N.J. Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells. Biol Reprod 57 (1997) 561-568
101. Towbin J.A., and Bowles L.E. The failing heart. Nature 415 (2000) 227-233
102. Tzahor E. Wnt/beta-catenin signaling and cardiogenesis: timing does matter. Dev Cell 13 1 (2007) 10-13
103. van Laake L.W., Passier R., Monshouwer-Kloots J., Nederhoff M.G., Ward-van Oostwaard D., Field L.J., et al. Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. Nat Protoc 2 10 (2007) 2551-2567
104. Wagner M., and Siddiqui M.A. Signal transduction in early heart development (II): ventricular chamber specification, trabeculation, and heart valve formation. Exp Biol Med (Maywood) 232 7 (2007) 866-880
105. Waksman R., Fournadjiev J., Baffour R., Pakala R., Hellinga D., Leborgne L., et al. Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium. Cardiovasc Radiat Med 5 3 (2004) 125-131
106. 2+ channel blockers. Differentiation 48 3 (1991) 173-182
107. Xie C.Q., Zhang J., Xiao Y., Zhang L., Mou Y., Liu X., et al. Transplantation of human undifferentiated embryonic stem cells into a myocardial infarction rat model. Stem Cells Dev 16 1 (2007) 25-29
108. Xu C., Police S., Rao N., and Carpenter M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91 (2002) 501-508
109. Xu C., Police S., Hassanipour M., and Gold J.D. Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells Dev 15 5 (2006) 631-639
110. Xu H., Morishima M., Wylie J.N., Schwartz R.J., Bruneau B.G., Lindsay E.A., et al. Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract. Development 131 13 (2004) 3217-3227
111. Xu X.Q., Graichen R., Soo S.Y., Balakrishnan T., Rahmat S.N.B., Sieh S., et al. Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation (2008) 10.1111/j.1432-0436.2008.00284.x
112. Xue T., Cho H.C., Akar F.G., Tsang S.Y., Jones S.P., Marbán E., et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 111 (2005) 11-20
113. Yang H.T., Tweedie D., Wang S., Guia A., Vinogradova T., Bogdanov K., et al. The ryanodine receptor modulates the spontaneous beating rate of cardiomyocytes during development. Proc Natl Acad Sci USA 99 14 (2002) 9225-9230
114. Yang Y., Min J.Y., Rana J.S., Ke Q., Cai J., Chen Y., et al. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol 93 (2002) 1140-1151
115. Zandstra P.W., Bauwens C., Yin T., Liu Q., Schiller H., Zweigerdt R., et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng 9 4 (2003) 767-778
116. Zijlstra M., Bix M., Simister N.E., Loring J.M., Raulet D.H., and Jaenisch R. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344 (1990) 742-746